跳至主要内容
临床试验/NCT07060183
NCT07060183撤回不适用

Aortic Valve Replacement for Moderate Aortic Stenosis With Left Ventricular Decompensation Early Feasibility Study

Dermed Diagnostics, Inc.0 个研究点开始时间: 2027年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
发起方
主要终点
Composite rates of all-cause mortality or morbidity

研究概览

简要总结

Obtain safety and effectiveness data to support expansion for aortic valve replacement to include patients with moderate aortic stenosis and left ventricular decompensation.

详细描述

Single-center prospective study. Subjects with moderate aortic stenosis and left ventricular decompensation will receive aortic valve replacement by the Ross procedure.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
55 Years 至 79 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Moderate aortic stenosis, defined by transthoracic echocardiograph
  • •Max aortic velocity less than 4.0 m/sec.
  • •Mean aortic gradient less than 40.0 mmHg.
  • •1.0 cm2 < Aortic Valve Area < 1.5 cm
  • •Left ventricular decompensation

排除标准

  • •Not suitable for the Ross procedure.
  • •Documented history of cardiac amyloidosis.

研究组 & 干预措施

Intervention

Experimental

Aortic Valve Replacement

干预措施: Ross procedure (Procedure)

Control

No Intervention

No intervention

结局指标

主要结局

Composite rates of all-cause mortality or morbidity

时间窗: 12 months

Composite rate of all-cause mortality, all-stroke, life threatening or fatal bleeding, acute kidney injury, hospitalization due to procedure-related complication, or valve dysfunction requiring reintervention.

次要结局

  • Left ventricular compensation(12 months)

研究者

发起方
Dermed Diagnostics, Inc.
申办方类型
Industry
责任方
Sponsor

相似试验